Clinical Research Directory
Browse clinical research sites, groups, and studies.
The CorEvitas Psoriasis (PSO) Registry
Sponsor: CorEvitas
Summary
The primary objective of the CorEvitas Psoriasis Registry is to study the comparative safety of approved psoriasis therapies in a North American cohort of psoriasis subjects treated by dermatologists. This includes assessing the incidence and nature of adverse events of special interest, including malignancy, in a real world population of psoriasis patients on new biologic therapies (e.g. secukinumab). Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, current treatment practices, and comparative effectiveness.
Official title: CorEvitas Psoriasis (PSO) Registry
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2015-04
Completion Date
2100-12
Last Updated
2026-02-09
Healthy Volunteers
No